FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 891 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge Adjuvant fractionated radiotherapy significantly improves DFS in patients with atypical meningioma who have undergone complete surgical resection MOST POPULAR Woman Finds Out She Has Breast Cancer From Museum Photo Booth November 1, 2019 Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer May 21, 2024 Five Questions with…Debra. March 31, 2022 How to Find an Oncologist Who’s an LGBTQ+ Ally: An Expert... April 14, 2021 Load more HOT NEWS New Low-Powered Implantable Device Monitors Soft Tissue for Signs of Breast... Inspiring the next generation of cancer researchers Does Eating Processed Meat Increase Your Risk for Cancer? American tobacco company Philip Morris International offers £1bn for UK pharma...
